NVAX · Novavax Inc · Webcasts, Transcripts & Audio
$10.59
+0.13 (+1.24%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$1.75B
Shares
164.95M
Volume · Oct 5
638.27K
Avg daily vol (3M)
4.45M
Novavax Inc Webcasts
Earnings calls, investor updates, investor days and conferences for Novavax Inc (NVAX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲310.7%
$734.58M
−$168.61M
'22 Q3
22-11-08
▲60.8%
$357.40M
−$182.25M
'22 Q4
23-02-28
▼88.5%
$80.95M
−$293.90M
'23 Q1
23-05-09
▲128.3%
$424.43M
$58.01M
'23 Q2
23-08-08
▼74.5%
$186.99M
−$130.78M
'23 Q3
23-11-09
▼18.5%
$291.34M
−$178.39M
'23 Q4
24-02-28
▲15.9%
$93.86M
−$147.55M
'24 Q1
24-05-10
▼2.1%
$415.48M
$162.38M
'24 Q2
24-08-08
▼54.8%
$84.51M
−$121.30M
'24 Q3
24-11-12
▼69.7%
$88.31M
−$81.03M
'24 Q4
25-02-27
▲610.3%
$666.65M
$518.65M
'25 Q1
25-05-08
▼42.4%
$239.24M
$106.51M
'25 Q2
25-08-06
▼16.6%
$70.44M
−$202.38M
'25 Q3
25-11-06
▲66.6%
$147.14M
$17.53M
'25 Q4
26-02-26
▼79.1%
$139.51M
−$9.49M
'26 Q1
26-05-06
LATEST
▼76.3%
$56.70M
−$53.39M
'26 Q2
26-08-06
Earnings call
FY26 · Q2
2026-08-06
Novavax Inc (NVAX) Q2 2026 Earnings Call
Revenue
$56.70M
▼ 76.3% YoY Diluted EPS
$-0.32
▼ 151.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-04
Novavax Inc (NVAX) June 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-06
Novavax Inc (NVAX) Q1 2026 Earnings Call Transcript
Confident tone
Matrix-M partnering strategy
R&D pipeline and preclinical assets
Sanofi partnership and Nuvaxovid
Revenue
$139.51M
▼ 79.1% YoY Diluted EPS
$-0.06
▼ 102% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Novavax Inc (NVAX) Q4 2025 Earnings Call Transcript
Confident tone
Partnership strategy and business development
Oncology and platform expansion
R&D pipeline and innovation
Revenue
$147.14M*
▲ 66.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Novavax Inc (NVAX) Q3 2025 Earnings Call Transcript
Positive tone
Sanofi partnership and transition activities
Matrix-M adjuvant and technology platform
Strategic transformation to partnership/R&D model
Revenue
$70.44M
▼ 16.6% YoY Diluted EPS
$-1.25
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
Novavax Inc (NVAX) Q2 2025 Earnings Call Transcript
Confident tone
Sanofi Partnership and Nuvaxovid BLA Approval
Strategic Priorities and Growth Platform
Oncology and Adjuvant Expansion
Revenue
$239.24M
▼ 42.4% YoY Diluted EPS
$0.62
▼ 37.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Novavax Inc (NVAX) Q1 2025 Earnings Call Transcript
Positive tone
New partnerships and collaborations
Sanofi partnership optimization
BLA approval and FDA process
Revenue
$666.65M
▲ 610.3% YoY Diluted EPS
$2.93
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
Novavax Inc (NVAX) Q4 2024 Earnings Call Transcript
Positive tone
Sanofi Partnership
Early-Stage Pipeline and Partnerships
CIC and Standalone Flu Phase 3
Revenue
$88.31M*
▼ 69.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Novavax Inc (NVAX) Q3 2024 Earnings Call Transcript
Positive tone
Late-stage pipeline (CIC and flu)
Financial guidance and revenue
COVID-19 commercial season and pricing
Revenue
$84.51M
▼ 54.8% YoY Diluted EPS
$-0.76
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Novavax Inc (NVAX) Q2 2024 Earnings Call Transcript
Positive tone
Sanofi partnership and value drivers
COVID-19 commercial readiness and BLA
Technology platform and business development
Revenue
$415.48M
▼ 2.1% YoY Diluted EPS
$0.99
▲ 70.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-10
Novavax Inc (NVAX) Q1 2024 Earnings Call Transcript
Confident tone
Sanofi Co-Development/Co-Commercialization Agreement
Regulatory Timing and Strain Selection
Matrix-M Adjuvant Platform Value
Revenue
$93.86M
▲ 15.9% YoY Diluted EPS
$-1.05
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-28
Novavax Inc (NVAX) Q4 2023 Earnings Call Transcript
Positive tone
APA Contract Revenue and Deliveries
Czech Manufacturing Plant Divestiture
COVID-Flu Combination Vaccine Pipeline
Revenue
$291.34M*
▼ 18.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-09
Novavax Inc (NVAX) Q3 2023 Earnings Call Transcript
Revenue
$186.99M
▼ 74.5% YoY Diluted EPS
$-1.26
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Novavax Inc (NVAX) Q2 2023 Earnings Call Transcript
Revenue
$424.43M
▲ 128.3% YoY Diluted EPS
$0.58
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Novavax Inc (NVAX) Q1 2023 Earnings Call Transcript
Revenue
$80.95M
▼ 88.5% YoY Diluted EPS
$-3.41
▼ 233.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-28
Novavax Inc (NVAX) Q4 2022 Earnings Call Transcript
Revenue
$357.40M*
▲ 60.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Novavax Inc (NVAX) Q3 2022 Earnings Call Transcript
Revenue
$734.58M
▲ 310.7% YoY Diluted EPS
$-2.15
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
Novavax Inc (NVAX) Q2 2022 Earnings Call Transcript
Revenue
$185.93M
▼ 37.6% YoY Diluted EPS
$-6.53
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-10
Novavax Inc (NVAX) Q1 2022 Earnings Call Transcript
Revenue
$703.97M
▲ 57.4% YoY Diluted EPS
$2.56
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-01
Novavax Inc (NVAX) Q4 2021 Earnings Call Transcript
Revenue
$222.20M*
▼ 20.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-05
Novavax Inc (NVAX) Q3 2021 Earnings Call Transcript
Revenue
$178.84M
▲ 13.9% YoY Diluted EPS
$-4.31
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-06
Novavax Inc (NVAX) Q2 2021 Earnings Call Transcript
Revenue
$298.02M
▲ 738.6% YoY Diluted EPS
$-4.75
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-11
Novavax Inc (NVAX) Q1 2021 Earnings Call Transcript
Revenue
$447.23M
▲ 13143.4% YoY Diluted EPS
$-3.05
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-02
Novavax Inc (NVAX) Q4 2020 Earnings Call Transcript
Revenue
$279.66M*
▲ 3072.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-10
Novavax Inc (NVAX) Q3 2020 Earnings Call Transcript
Revenue
$157.02M
▲ 6163.4% YoY Diluted EPS
$-3.21
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-11
Novavax Inc (NVAX) Q2 2020 Earnings Call Transcript
Revenue
$35.54M
▲ 958.6% YoY Diluted EPS
$-0.30
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-12
Novavax Inc (NVAX) Q1 2020 Earnings Call Transcript
Revenue
$3.38M
▼ 15.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-12
Novavax Inc (NVAX) Q4 2019 Earnings Call
Revenue
$8.82M
▲ 43.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–28 of 28 webcasts